Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer

Clinical Cancer Research

Volumn 13, Issue 19, 2007, Pages 5745-5755

  Guan, Yinghui ^a   Kuo, Wen Lin ^a   Stilwell, Jackie L ^c   Takano, Hirokuni ^d   Lapuk, Anna V ^a   Fridlyand, Jane ^e   Mao, Jian Hua ^b   Yu, Mamie ^b   Miller, Melinda A ^f   Santos, Jennifer L ^g   Kalloger, Steve E ^h   Carlson, Joseph W ^a   Ginzinger, David G ^b   Celniker, Susan E ^a   Mills, Gordon B ⁱ   Huntsman, David G ^h   Gray, Joe W ^a,c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Trubion Pharmaceuticals   (United States)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e GENENTECH INC   (United States)

^f Centre for Translational and Applied Genomics   (Canada)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CHROMOSOME 8Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PVT1 GENE; TISSUE MICROARRAY;

APOPTOSIS; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OVARIAN NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 35348925443     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2882     Document Type: Article

References (31)

1. Lancaster JM, Dressman HK, Whitaker RS, et al. Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Investig 2004;11:51-9.
2. Popescu NC, Zimonjic DB. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 2002;6:151-9.
3. Shtivelman E, Henglein B, Groitl P, Lipp M, Bishop JM. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A 1989;86:3257-60.
4. Cory S, Graham M, Webb E, Corcoran L, Adams JM. Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J 1985;4:675-81.
5. Webb E, Adams JM, Cory S. Variant (6;15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene. Nature 1984;312:777-9.
6. Graham M, Adams JM, Cory S. Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature 1985;314:740-3.
7. Graham M, Adams JM. Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J 1986;5:2845-51.
8. + T cell and c-myc amplified tumours. EMBO J 1987;6:1959-65.
9. Shtivelman E, Bishop JM. The PVT gene frequently amplifies with MYC in tumor cells. Mol Cell Biol 1989;9:1148-54.
10. Shtivelman E, Bishop JM. Effects of translocations on transcription from PVT. Mol Cell Biol 1990;10:1835-9.
11. Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006;10:515-27.
12. Hodgson G, Hager JH, Volik S, et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001;29:459-64.
13. Hackett CS, Hodgson JG, Law ME, et al. Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. Cancer Res 2003;63:5266-73.
14. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
15. Lapuk A, Volik S, Vincent R, et al. Computational BAC clone contig assembly for comprehensive genome analysis. Genes Chromosomes Cancer 2004;40:66-71.
16. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix Gene-Chip probe level data. Nucleic Acids Res 2003;31:e15.
17. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002;30:503-12.
18. Stilwell JL, Guan Y, Neve RM, Gray JW. Systems biology in cancer research: genomics to cellomics. Methods Mol Biol 2007;356:353-65.
19. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res 2004;32:D109-11.
20. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
21. Murchison EP, Hannon GJ. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol 2004;16:223-9.
22. Mingeot-Leclercq MP, Brasseur R, Schanck A. Molecular parameters involved in aminoglycoside nephrotoxicity. J Toxicol Environ Health 1995;44:263-300.
23. Levee MG, Dabrowska MI, Lelli JL Jr, Hinshaw DB. Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 1996;271:C1981-92.
24. Okada T, Otani H, Wu Y, et al. Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation. Am J Physiol Heart Circ Physiol 2005;289:H2310-8.
25. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 2004;32:D523-7.
26. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 2007;7:3-18.
27. Bergstralh DT, Ting JP. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev 2006;32:166-79.
28. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509-12.
29. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004.
30. McManus MT. MicroRNAs and cancer. Semin Cancer Biol 2003;13:253-8.
31. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006;15 Spec No 1:R17-29.